Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cti Biopharm Corp (NQ: CTIC )

3.300 USD +0.050 (+1.54%)
Official Closing Price Updated: 7:55 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 402,193
Open 3.240
Bid (Size) 3.320 (5)
Ask (Size) 3.340 (3)
Prev. Close 3.250
Today's Range 3.220 - 3.350
52wk Range 0.6200 - 4.030
Shares Outstanding 57,976,631
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a... 
From PR Newswire
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to three new employees with a grant date of February 24, 2021, as... 
From PR Newswire

Performance

YTD
-1.79%
-1.79%
1 Month
-1.20%
-1.20%
3 Month
-8.33%
-8.33%
6 Month
+197.30%
+197.30%
1 Year
+236.73%
+236.73%

More News

Read More
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15
From PR Newswire
CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Potential Benefit in Preventing Acute GVHD at the 62nd American Society of Hematology Meeting
From PR Newswire
CTI BioPharma Announces Publication of Article Highlighting Pacritinib Data from the PAC203 Phase 2 Study in Myelofibrosis in Blood Advances
From PR Newswire
CTI BioPharma Reports Third Quarter 2020 Financial Results
From PR Newswire
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
Tags Market News ABBV CTIC
From Motley Fool
First Week of January 2021 Options Trading For CTI BioPharma (CTIC)
Tags Stocks
From Market News Video
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Tags GLYC ENZ CTIC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.